Southernwood

Southernwood (Artemisia abrotanum L.): A Comprehensive Reference

1. Identity: Botanical Classification, Names, and Physical Description

Artemisia abrotanum, the southernwood, lad's love, or southern wormwood, is a species of flowering plants in the sunflower family (Asteraceae). It is a shrub-like herbaceous perennial belonging to the Asteraceae family. It is native to Eurasia and Africa but naturalized in scattered locations in North America. Southernwood is native to Southern Europe, most likely in countries along the Mediterranean from Spain to Italy.

The genus name Artemisia is named for Artemis, the Greek goddess of the moon, wild animals, and hunting. The specific epithet from Greek means "wormwood" or "southernwood," which are the most common names for Artemisia abrotanum. In English, it is commonly called southernwood, a name with Old English roots denoting a "woody plant from the south," distinguishing it from northern species of wormwood due to its Eurasian origins.

Common names are numerous across cultures and languages. Other common names include: old man, boy's love, oldman wormwood, lover's plant, appleringie, garderobe, Our Lord's wood, maid's ruin, garden sagebrush, European sage, sitherwood, and lemon plant. In France, it is called garderobe, which means "guard the wardrobe," referring to the old practice of placing plant sprigs where you would put your clothes to deter moths and other insects.

Pharmacognostic raw material designations: The raw materials obtained from this species are Abrotani herba and Abrotani folium.

Morphology: Southernwood is a shrub-like plant that grows perennially to a height of about three feet (one meter) and possesses a potent aroma. The stems are woody, while it bears fluffy leaves that have a silver-green hue. It typically grows in a bushy clump, 2–4 ft. tall (60–120 cm) and 2–3 ft. wide (60–90 cm). Blooming in loose panicles from late summer to fall, its small, nodding, yellow-white flowers are inconspicuous. It forms an upright, bushy mound, which releases a pleasant citrus to camphor fragrance whenever brushed or touched.

Synonyms: The species has been published under the synonyms Artemisia paniculata and Artemisia procera Willd., though Artemisia abrotanum L. is the accepted binomial.

2. Common Forms and Preparations

Southernwood is prepared and used in a variety of forms, spanning culinary, medicinal, and domestic applications:

• Dried herb (Abrotani herba): The aerial parts — stems and leaves — dried and used in infusions (teas), decoctions, or as loose bulk herb.
• Dried leaf (Abrotani folium): Leaf material separated from stems and dried for use in teas or powdered preparations.
• Fluid extract: The oral dose of a fluid extract of A. abrotanum (1:1 in 25% aqueous ethanol) was reported as 2 to 4 ml, three times a day.
• Essential oil: Obtained by hydrodistillation of the aerial plant parts; used in research contexts and as a base for topical or inhalational preparations.
• Nasal spray: A pharmaceutical preparation incorporating an essential oil and flavonol extract has been described in clinical research (see Section 5).
• Sachets and potpourri: The leaves of southernwood retain their fragrance after drying and may be used in sachets, as air fresheners, or for discouraging clothing moths.
• Homeopathic preparations: In the official European medicine, this plant species is recommended by the French Pharmacopoeia for use in homeopathy.
• Cosmetic ingredients: A. abrotanum is recommended by the European Cosmetic Ingredients Database (CosIng) as a source of valuable cosmetic ingredients.

3. Traditional and Historical Use

Artemisia abrotanum L. (southern wormwood) is a plant species with an important position in the history of European and Asian medicine. It is a species famous as a medicinal plant in Central Asia, Asia Minor, and in South-East and Central Europe.

3.1 Ancient Greece and Rome

Artemisia abrotanum is a species of plant that has been traditionally used in Greek and Roman medicine to relieve respiratory complications, improve breathing, and act as a spasmolytic. The plant belonged to a broad family of medicinal Artemisia species recognized in classical antiquity, and its uses overlapped substantially with those of close relatives.

3.2 Medieval and Renaissance Europe

In medieval Europe, Artemisia abrotanum served as a popular strewing herb, scattered across floors in homes and large manors to mask odors, freshen the air, and repel insects due to its strong camphor-like scent. This practice was widespread in households lacking modern sanitation, where the aromatic foliage helped maintain a more pleasant environment.

It was customary to lay sprays of the herb amongst clothes, or to hang them in closets, and this is the origin of one of the southernwood's French names, "garderobe" ("clothes-preserver"). Judges carried posies of southernwood and rue to protect themselves from prisoners' contagious diseases, and some churchgoers relied on the herb's sharp scent to keep them awake during long sermons.

One of the most important Polish Renaissance herbals — "Zielnik" by Simon Syrenius — mentions the plant's drying and warming effects as well as its effectiveness as a remedy against "venoms and poisons" (after Dioscorides and Pliny), repelling "venomous animals," and in diseases of the lungs and the digestive system, and in women's diseases. A. abrotanum was also used as an antipyretic, against internal parasites, and externally in the treatment of scalp and hair diseases, and as an anti-inflammatory medication in eye diseases and ulcers of various origins. The plant was used to prepare an oil with analgesic and diuretic properties, wine stimulating the appetite and effective against jaundice, and vodka for respiratory ailments.

3.3 Scandinavian Tradition

The plant held notable cultural significance in Scandinavian traditions, particularly in Sweden, where it became a staple in church bouquets carried by peasant women during Lutheran services from the 16th century until the late 19th century. It has been mentioned as early as the sixteenth century in Swedish-Danish medicinal books that it was used as a treatment for people and animals. The pre-industrial custom of including southernwood and other floral species in church bouquets underwent gradual regression in connection with the social changes that took place in connection with industrialization and modernization. The documentation and findings of A. abrotanum from Swedish national inventories for cultivated plants correspond to older ethnobotanical records and literature.

3.4 Traditional European Medicinal Applications

In traditional European medicine, southernwood has been used most of all in liver and biliary tract diseases, in parasitic diseases in children, and as antipyretic medication. In many European countries, it is used traditionally in allopathy.

A. abrotanum was traditionally used as an antiseptic, astringent, emmenagogue, antidiabetic, expectorant, febrifuge, stomachic, antimalarial, anti-inflammatory, vermifuge, and spasmolytic, and used for treating upper respiratory tract disease, antibacterial, antifungal, cancer, cough, and fever.

The leaves of A. abrotanum are used internally to improve digestion and liver function, encourage menstrual flow and stimulate the uterus, lower fever, relax spasms, and destroy intestinal worms. In the traditional medicine of East and North Bosnia and Herzegovina, aerial parts of Artemisia abrotanum are used in jaundice therapy.

Southernwood is also known as "lad's love" due to the belief that it would encourage beards to grow, and it was also made into a hair pomade.

3.5 Textile and Dye Use

A yellow dye can be extracted from the branches of the plant for use with wool. Branches of the plant were employed to extract a yellow dye for coloring wool, a technique documented in early herbal texts and utilized in textile production.

4. Key Constituents and Active Compounds

Artemisia abrotanum occupies an important position in the history of European and Asian medicine, and this is reflected in its diverse phytochemistry. The plant's biological activity derives from multiple classes of secondary metabolites.

4.1 Essential Oil (Volatile Fraction)

The essential oil is the most extensively studied fraction and exhibits considerable compositional variability depending on geographic origin, chemotype, and growth stage. Some of the latest investigations emphasize the large differences in the composition of the essential oil, determined by the geographical (climatic) origin of the plant.

In one Lithuanian study, the main compounds of the leaf essential oil were α-thujone (45.5%), β-thujone (11.4%), trans-sabinyl acetate (10.1%), 1,8-cineole (7.4%), and camphor (6.8%).

In a separate analysis of the herb of Artemisiae abrotani herba, fifty-six compounds of the oil were identified, of which (+)-piperitone was the major component (20.38–38.48%).

Davanone and derivatives thereof, compounds with silphiperfolane skeleton, estragole, davanone oil, β-thujone, sabinyl acetate, herniarin, cis-chrysanthenyl acetate, 1,8-cineol, and terpineol were identified among the main components of Artemisia volatiles.

The most important constituents in the essential oil fraction of a well-characterized nasal spray preparation were 1,8-cineole, linalool, and davanone.

Key monoterpene and sesquiterpene components thus include: α-thujone, β-thujone, camphor, 1,8-cineole (eucalyptol), linalool, davanone, piperitone, trans-sabinyl acetate, and silphiperfolane-skeleton sesquiterpenes, among others. The proportions vary markedly between chemotypes and regions.

4.2 Non-Volatile Constituents

Among the non-volatile constituents, an alkaloid abrotin and coumarins (isofraxidin, umbelliferon), flavonoid glycosides (rutin), and free flavonol ethers (various isomeric quercetin dimethyl ethers) are reported.

Although southernwood contains bitter sesquiterpene lactones of the absinthin type, it is still less bitter than its close relative, wormwood (A. absinthium).

The flavonol fraction of a pharmacologically characterized extract was found to contain centauredin, casticin, and quercetin dimethyl-ethers. The main substances obtained from the plant that are responsible for its documented biological activity are: the essential oil, coumarins, phenolic acids, and flavonoids.

Artemisia species primarily contain sesquiterpenoid lactones, coumarins, flavonoids, and phenolic acids — all of which are present in A. abrotanum and contribute to its pharmacological profile.

4.3 Thujone Content and Chemotype Variation

Thujone is also found in southernwood's close relatives mugwort and particularly wormwood, and in unrelated species like thuja or sage. Importantly, however, the degree to which thujone is present in A. abrotanum is strongly chemotype-dependent. No trace of thujone was observed in the essential oil of the Artemisia abrotanum L. genotype "Tycho," used for the manufacture of a studied nasal spray preparation. This highlights that chemotype selection is critical when assessing safety and activity.

4.4 Mechanisms of Action (Established and Proposed)

Recent professional studies have proven previously unknown biological activities of extracts from the herb and/or the leaves, and/or the distilled essential oil, namely antibacterial, antifungal, antioxidant, anticancer, and antiallergic properties. Apart from the essential oil, the coumarins, phenolic acids, and flavonoids present in the chemical composition of the plant are also responsible for the abovementioned biological effects.

The antioxidant mechanism is partly understood: the antioxidant activity of Artemisia ssp. extracts is conditioned mainly by the presence of flavonoids and other polyphenol compounds. Specific flavonols such as centauredin, casticin, and quercetin dimethyl-ethers are well known for their anti-inflammatory effects, operating by modulating inflammatory cytokine pathways.

A 2024 study investigating A. abrotanum ethanol extracts examined anti-inflammatory mechanisms in detail: the anti-inflammatory effect was evaluated by analyzing the level of NfkB-p65 as well as NLRP3 inflammasome activation by measuring IL-1β, IL-18, and gasdermin D — mechanisms not previously documented for this species.

5. Scientific Evidence by Area of Use

5.1 Allergic Rhinitis and Upper Airway Disorders

This represents the area with the most directly applicable human clinical data for A. abrotanum specifically.

A nasal spray formulation containing an extract of Artemisia abrotanum L. was developed for therapeutic use in patients with allergic rhinitis and other upper airway disorders. The nasal spray preparation used contains a mixture of essential oils (4 mg/ml) and flavonols (2.5 μg/ml), of which some components have been shown to possess anti-inflammatory, expectorant, spasmolytic, as well as antiseptic and antimicrobial activities.

A clinical study used this nasal spray, containing extract of A. abrotanum mainly composed of essential oil (4 mg/mL) and flavonols (2.5 μg/mL), to treat 12 patients with allergic rhinitis. The essential oil fraction is composed of 1,8-cineole, linalool, and davanone, while the flavonol fraction contained centauredin, casticin, and quercetin dimethyl-ethers, which are well known for their anti-inflammatory effect.

In 12 patients with diagnoses of allergic rhinitis, allergic conjunctivitis, and/or bronchial obstructive disease, the nasal spray was given immediately after the appearance of characteristic allergic nasal symptoms. All patients experienced a rapid and significant symptom relief of nasal symptoms, comparable to the effect of antihistamine and chromoglicate preparations which several of the patients had used previously. The effect was present within 5 minutes after administration and lasted for several hours. In 7 of the 10 rhinitis patients with concomitant symptoms of allergic conjunctivitis, a significant subjective relief of eye symptoms was also experienced.

Artemisia abrotanum L. exhibited histamine suppression effect when prepared as a nasal spray preparation. The use of nasal spray preparation has shown a rapid onset of action and relief of nasal symptoms such as congestion, rhinorrhea, and sneezing within a few minutes of application.

Evidence assessment: This is a small, uncontrolled pilot study of only 12 patients and lacks randomization, blinding, or a placebo control arm. Results are preliminary and hypothesis-generating only. No randomized controlled trials (RCTs) on A. abrotanum for allergic rhinitis have been identified in the literature.

5.2 Antifungal Activity

A study investigated the chemical composition and the activity against Candida albicans of volatile oils obtained from Artemisia dracunculus, A. abrotanum, A. absinthium, and A. vulgaris. The essential oils shared common components but presented differences in composition and showed variable antifungal activity. Davanone and derivatives thereof, compounds with silphiperfolane skeleton, estragole, davanone oil, β-thujone, sabinyl acetate, herniarin, cis-chrysanthenyl acetate, 1,8-cineol, and terpineol were among the main components identified. Among the volatile fractions tested, those from A. abrotanum containing davanone or silphiperfolane derivatives showed the highest antifungal activity. The in vitro tests revealed that the Artemisia oils are promising candidates for further research to develop novel anti-candida drugs.

Evidence assessment: All antifungal evidence for A. abrotanum specifically is in vitro (laboratory-based) only. No human studies exist. Evidence is preliminary.

5.3 Antibacterial Activity

Studies on the biological activity of extracts from the aboveground parts of the plant and/or the leaves, and/or the essential oil have provided evidence of possible applications related to antibacterial properties. From a cosmetic point of view, a very interesting scientifically proven activity against Propionibacterium acnes strains has been reported for the extracts from the herb of A. abrotanum and A. absinthium. Studies have shown that these extracts can be used to create new therapeutic and cosmetic products for the treatment of acne and for skincare.

Evidence assessment: Antibacterial data for A. abrotanum are derived from in vitro microbiological assays. There are no human clinical trials for any infectious indication. Evidence is preliminary and preclinical.

5.4 Antioxidant and Anti-Inflammatory Activity

A 2024 study aimed to investigate the antioxidant and anti-inflammatory activities mechanism of A. dracunculus and A. abrotanum ethanol extracts in acute rat inflammation induced in Wistar male rats with turpentine oil. The antioxidant activity of the extracts was evaluated in vitro by DPPH, FRAP, H₂O₂, and NO scavenging tests, and in vivo by measuring the total oxidative status (TOS), total antioxidant capacity (TAC), oxidative stress index (OSI), 8-hydroxy-deoxyguanosine (8-Oxo-dG), advanced oxidation protein products (AOPP), malondialdehyde (MDA), nitric oxide (NO), 3-nitrotyrosine (3NT), and total thiols (SH). The anti-inflammatory effect was evaluated by the level of NfkB-p65 and NLRP3 inflammasome activation by measuring IL-1β, IL-18, and gasdermin D — mechanisms not previously documented for this species.

Evidence assessment: Anti-inflammatory and antioxidant evidence for A. abrotanum is limited to in vitro assays and animal models (rats). No controlled human clinical trials exist. Evidence is preclinical.

5.5 Anticancer (Cytotoxic) Activity

Studies on biological activity of extracts from the aboveground parts of the plant and/or the essential oil have provided evidence of possible applications related to anticancer properties. Recent professional studies have proven previously unknown biological activities of extracts from the herb and/or the leaves, and/or the distilled-off essential oil, including anticancer properties.

Evidence assessment: Anticancer evidence for A. abrotanum is in vitro (cell-line cytotoxicity assays) only. This is standard early-stage screening data. No animal studies or human trials on cancer outcomes have been identified for this species.

5.6 Insect Repellent Activity

The latest studies have also focused on the repellent activity of the essential oil of this species and the possibility to use it in the prevention of diseases in which insects are the vectors. Its dried leaves are used to keep moths away from wardrobes. The volatile oil in the leaves is responsible for the strong, sharp scent which repels moths and other insects.

Evidence assessment: Insect repellent use has historically strong empirical support and is referenced across centuries of ethnobotanical use. Laboratory studies support the activity of the volatile oil against some insect species. No rigorous human field-trial data are available.

5.7 Liver and Biliary Tract

The herb of this species — Abrotani herba — occupies an important position in the traditional medicine of European countries. It is recommended most often for the treatment of diseases of the liver and the biliary tract. It is also used as an effective anthelmintic in children, and as an antipyretic.

In the traditional medicine of East and North Bosnia and Herzegovina, aerial parts of Artemisia abrotanum are used in jaundice therapy.

Evidence assessment: Liver and biliary use is entirely based on traditional/ethnobotanical evidence. There are no clinical or preclinical pharmacological studies specifically on A. abrotanum for hepatic or biliary endpoints identified in the literature. The hepatoprotective evidence documented for the Artemisia genus more broadly derives from related species such as A. dracunculus and A. absinthium.

5.8 Digestive and Appetite-Stimulating Use

The leaves of A. abrotanum are used internally to improve digestion and liver function. The plant was used to prepare a wine stimulating the appetite and effective against jaundice. The bitter sesquiterpene lactones present in the plant are consistent with bitter tonic / choleretic activity seen across related Artemisia species; however, no clinical trials specifically for A. abrotanum in digestive indications have been identified.

Evidence assessment: Digestive use is traditional. Mechanistic plausibility exists via bitter compounds (sesquiterpene lactones). Clinical evidence specific to this species is absent.

6. Body Systems Associated with Southernwood

• Respiratory system: Traditional use as expectorant, spasmolytic, and for upper respiratory tract complaints; the allergic rhinitis nasal spray study represents the only clinical data.
• Digestive/hepatobiliary system: Traditional use for liver disease, jaundice, poor digestion, and appetite stimulation.
• Immune/allergic system: Demonstrated (preclinically and in a small clinical study) antiallergic and anti-inflammatory effects; activity against P. acnes relevant to dermatological conditions.
• Reproductive system: Historically used as an emmenagogue (to stimulate menstrual flow) and uterine stimulant; these uses require serious safety consideration (see Section 8).
• Integumentary system (skin/hair): Traditional topical use for scalp conditions; cosmetic applications under research; activity against acne-causing bacteria.
• Antimicrobial domain: In vitro antibacterial and antifungal activity, particularly notable against Candida albicans.
• Antiparasitic: Traditional use as a vermifuge (anthelmintic) in children, particularly cited in European ethnomedicine.

7. Dosage Forms and Reported Dosages

Formal pharmacopoeial monographs for A. abrotanum specifically are limited. In the official European medicine, this plant species is recommended by the French Pharmacopoeia for use in homeopathy. In many European countries, it is used traditionally in allopathy.

The following dosages have been reported in identified sources:

• Fluid extract (oral): The oral dose of a fluid extract of A. abrotanum (1:1 in 25% aqueous ethanol) was reported as 2 to 4 ml, three times a day.
• Nasal spray (clinical study): A nasal spray formulation used in the clinical study contained an extract of Artemisia abrotanum L. with a mixture of essential oils (4 mg/ml) and flavonols (2.5 μg/ml).
• General preparation note: Some of the latest investigations emphasize the large differences in the composition of the essential oil, determined by the geographical (climatic) origin of the plant — meaning that dose and potency will differ substantially between commercially available preparations depending on chemotype and origin.

No standardized dose ranges, dosage durations, or formal dose-finding studies specific to A. abrotanum have been identified in the peer-reviewed literature beyond those cited above. The absence of a Commission E or ESCOP monograph for A. abrotanum itself (as distinct from related Artemisia species) means there is no institutional dosage guidance comparable to that available for, e.g., A. absinthium.

8. Safety Considerations and Interactions

8.1 Observed Safety in Human Studies

Studies on patients taking homeopathic remedies, herbal mixtures, or single-ingredient preparations from A. abrotanum extracts have reported no serious adverse effects. In a previous study, only two patients out of 236 studied showed side effects. The intake of a preparation composed of A. abrotanum and Matricaria recutita extracts was reported to cure ailments such as stomach pain and allergy.

8.2 Thujone: Variable Presence and Toxicological Concern

Thujone is found in southernwood's close relatives mugwort and particularly wormwood. It is rather poisonous and generally held responsible for the toxicity of alcoholics containing wormwood extracts. However, as noted above, thujone levels in A. abrotanum are highly chemotype-dependent. No trace of thujone was observed in the essential oil of the Artemisia abrotanum L. genotype "Tycho." In contrast, some Lithuanian specimens yielded essential oils in which α-thujone constituted 45.5% of the oil. The European Food Safety Authority (EFSA) has classified α- and β-thujone as potentially hazardous compounds.

The species A. absinthium is rich in compounds that have toxic effects, of which α- and β-thujone deserve particular attention, with α-thujone being thought to be two to three times more harmful. The EFSA listed α- and β-thujone, absinthin, and anabsinthin as potentially dangerous. While this designation applies formally to A. absinthium, the potential for thujone in certain chemotypes of A. abrotanum means this concern is not irrelevant to southernwood preparations of unknown geographic origin.

8.3 Emmenagogue and Uterine-Stimulant Properties

Medicinal plants containing thujone have been traditionally used as abortifacients, contraceptives, and uterotonics, as well as for the treatment of amenorrhoea and uterine carcinomas. The leaves of A. abrotanum are used internally to encourage menstrual flow and stimulate the uterus, a use documented in traditional European medicine. These properties make its use during pregnancy a matter of serious concern from a historical pharmacological perspective.

8.4 Bitterness and Gastrointestinal Sensitivity

Although southernwood contains bitter sesquiterpene lactones of the absinthin type, it is still less bitter than its close relative, wormwood. Careful dosage is essential. The bitter compounds may cause gastric irritation in sensitive individuals, particularly at higher doses.

8.5 Allergic Potential (Contact Dermatitis)

Artemisia species are established members of the Asteraceae (Compositae) family, and sesquiterpene lactones from this family are well-recognized contact allergens. While specific contact sensitization data for A. abrotanum are not extensively documented in the sources retrieved, cross-reactivity with other Asteraceae allergens is pharmacologically plausible and should be considered in individuals with known Asteraceae hypersensitivity.

8.6 Absence of Formal Drug Interaction Data

No formal pharmacokinetic drug interaction studies for A. abrotanum have been identified in the sources reviewed. The presence of coumarins (including umbelliferon and isofraxidin) in the plant raises theoretical questions about potential interactions with anticoagulant medications, as coumarins can affect coagulation pathways, but no clinical evidence specific to A. abrotanum and drug interactions was located.

8.7 Cosmetic and Topical Safety

A. abrotanum is recommended by the European Cosmetic Ingredients Database (CosIng) as a source of valuable cosmetic ingredients, indicating regulatory-level recognition of its use in topical/cosmetic applications within the European Union framework.

9. Regulatory and Pharmacopoeial Status

In the official European medicine, this plant species is recommended by the French Pharmacopoeia for use in homeopathy. There are no EMA/HMPC community herbal monographs for A. abrotanum (as distinct from A. absinthium, which has a full EMA assessment report and monograph). Artemisia abrotanum L. is a plant species with an important position in the history of European and Asian medicine, famous as a medicinal plant in Central Asia, Asia Minor, and in South-East and Central Europe, yet it remains without a comprehensive regulatory monograph comparable to those of its better-studied relatives. A. abrotanum is recommended by the European Cosmetic Ingredients Database (CosIng) as a source of valuable cosmetic ingredients. Additionally, the leaves of this species possess a well-established position in the food industry.

10. Summary of Evidence Strength

• Allergic rhinitis (nasal spray): One small (n=12), uncontrolled, open-label human pilot study; positive signals but insufficient to establish efficacy. Evidence level: very preliminary.
• Antifungal (anti-Candida): In vitro only. No human or animal data. Evidence level: preclinical/preliminary.
• Antibacterial / anti-acne: In vitro microbiological assays only. Evidence level: preclinical/preliminary.
• Anti-inflammatory / antioxidant: In vitro assays and animal (rat) models. Evidence level: preclinical.
• Anticancer: In vitro cell-line assays only. Evidence level: preclinical/preliminary.
• Liver and biliary, digestive, antipyretic, anthelmintic, emmenagogue: Traditional ethnobotanical evidence only; no controlled clinical studies identified. Evidence level: traditional use / anecdotal.
• Insect repellent: Strong historical/ethnobotanical evidence; supported by in vitro/laboratory work on the volatile oil. Evidence level: empirical/traditional, with supportive laboratory data.

References

• Ekiert H, et al. Artemisia abrotanum L. (Southern Wormwood)—History, Current Knowledge on the Chemistry, Biological Activity, Traditional Use and Possible New Pharmaceutical and Cosmetological Applications. Molecules. 2021;26(9):2503. PMC8123286.
• Bilia AR, et al. Chemical characterization by GC-MS and in vitro activity against Candida albicans of volatile fractions prepared from Artemisia dracunculus, Artemisia abrotanum, Artemisia absinthium and Artemisia vulgaris. PMC3907663.
• Bora KS, Sharma A. Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles. PMC9467740.
• Ekiert H, et al. Artemisia Species with High Biological Values as a Potential Source of Medicinal and Cosmetic Raw Materials. PMC9571683.
• Țicolea M, et al. Phytochemical Composition Antioxidant and Anti-Inflammatory Activity of Artemisia dracunculus and Artemisia abrotanum. Antioxidants. 2024;13(8):1016. PMC11352149.
• Remberg P, et al. Characteristics, clinical effect profile and tolerability of a nasal spray preparation of Artemisia abrotanum L. for allergic rhinitis. PubMed 14971719.
• Svanberg I, et al. "It may also have prevented churchgoers from falling asleep": southernwood, Artemisia abrotanum L. (fam. Asteraceae), in the church bouquet, and its contemporary presence as a heritage plant in Sweden. PMC7456030.
• Wikipedia. Artemisia abrotanum.
• iNaturalist. Artemisia abrotanum (Southernwood).
• Missouri Botanical Garden Plant Finder. Artemisia abrotanum.
• USDA Forest Service Fire Effects Information System. Artemisia abrotanum. Howard, Janet L. 1998.
• Katzer G. Spice Pages: Southernwood (Artemisia abrotanum).
• GlobinMed. Artemisia abrotanum L.
• Frontiers in Pharmacology. Anti-Allergic Rhinitis Effects of Medicinal Plants and Their Bioactive Metabolites via Suppression of the Immune System: A Mechanistic Review. 2021.
• Judzentiene A, et al. Essential oil composition of Artemisia abrotanum L. during different vegetation stages in Lithuania. Academia.edu.